Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-08 3:26 pm Sale | 2026-03-31 | 13G | PAR TECHNOLOGY CORP PAR | T. Rowe Price Investment Management Inc. | 2,612,424 6.100% | -2,988,220![]() (-53.35%) | Filing History |
| 2026-04-08 3:26 pm Sale | 2026-03-31 | 13G | PERSONALIS INC PSNL | T. Rowe Price Investment Management Inc. | 4,758,091 4.500% | -6,022,199![]() (-55.86%) | Filing History |
| 2026-04-08 3:26 pm Purchase | 2026-03-31 | 13G | BICARA THERAPEUTICS INC BCAX | T. Rowe Price Investment Management Inc. | 6,605,780 10.100% | 3,369,185![]() (+104.10%) | Filing History |
| 2026-04-08 3:26 pm Sale | 2026-03-31 | 13G | QUIDELORTHO CORPORATION QDEL | T. Rowe Price Investment Management Inc. | 5,629,965 8.300% | -5,608,861![]() (-49.91%) | Filing History |
| 2026-04-08 3:26 pm Purchase | 2026-03-31 | 13G | APOGEE THERAPEUTICS INC APGE | T. Rowe Price Investment Management Inc. | 10,291,220 16.800% | 4,077,393![]() (+65.62%) | Filing History |
| 2026-03-06 12:57 pm Sale | 2026-02-28 | 13G | I3 VERTICALS INC CLASS A COM IIIV | T. Rowe Price Investment Management Inc. | 705,316 3.200% | -2,469,000![]() (-77.78%) | Filing History |
| 2026-03-06 12:57 pm Purchase | 2026-02-28 | 13G | DYNE THERAPEUTICS INC DYN | T. Rowe Price Investment Management Inc. | 26,578,437 16.200% | 9,038,348![]() (+51.53%) | Filing History |
| 2026-03-06 12:57 pm Sale | 2026-02-28 | 13G | CCC INTELLIGENT SOLUTIONS HLDG CCC | T. Rowe Price Investment Management Inc. | 20,406,409 3.400% | -54,265,970![]() (-72.67%) | Filing History |
| 2026-03-06 12:57 pm Sale | 2026-02-28 | 13G | IMMUNOCORE HLDGS PLC ADS IMCR | T. Rowe Price Investment Management Inc. | 3,041,904 6.000% | -2,919,323![]() (-48.97%) | Filing History |
| 2026-03-06 12:57 pm Sale | 2026-02-28 | 13G | ARCELLX INC ACLX | T. Rowe Price Investment Management Inc. | 2,653,848 4.500% | -7,906,577![]() (-74.87%) | Filing History |
| 2026-03-06 12:57 pm Purchase | 2026-02-28 | 13G | APOGEE THERAPEUTICS INC APGE | T. Rowe Price Investment Management Inc. | 6,213,827 11.300% | 6,213,827![]() (New Position) | Filing History |
| 2026-02-17 10:28 am Sale | 2025-12-31 | 13G | VIAVI SOLUTIONS INC DE VIAV | T. Rowe Price Investment Management Inc. | 8,497,432 3.800% | -2,731,248![]() (-24.32%) | Filing History |
| 2026-02-17 10:28 am Purchase | 2025-12-31 | 13G | PLANET FITNESS, INC CLASS A CO PLNT | T. Rowe Price Investment Management Inc. | 9,236,173 11.100% | 829,045![]() (+9.86%) | Filing History |
| 2026-02-17 10:28 am Purchase | 2025-12-31 | 13G | INGERSOLL RAND INC IR | T. Rowe Price Investment Management Inc. | 21,791,309 5.500% | 4,309,208![]() (+24.65%) | Filing History |
| 2026-02-17 10:28 am Purchase | 2025-12-31 | 13G | PROCEPT BIOROBOTICS CORP COM PRCT | T. Rowe Price Investment Management Inc. | 3,271,408 5.900% | 2,239,681![]() (+217.08%) | Filing History |
| 2026-02-17 10:28 am Sale | 2025-12-31 | 13G | CABALETTA BIO INC CABA | T. Rowe Price Investment Management Inc. | 9,858,257 10.200% | -502,069![]() (-4.85%) | Filing History |
| 2026-02-17 10:28 am Purchase | 2025-12-31 | 13G | EASTERN BANKSHARES INC EBC | T. Rowe Price Investment Management Inc. | 13,728,558 5.800% | 3,911,476![]() (+39.84%) | Filing History |
| 2026-02-17 10:28 am Purchase | 2025-12-31 | 13G | USCB FINL HLDGS INC USCB | T. Rowe Price Investment Management Inc. | 1,316,580 7.300% | 66,580![]() (+5.33%) | Filing History |
| 2026-02-17 10:28 am Sale | 2025-12-31 | 13G | PRIME MEDICINE INC PRME | T. Rowe Price Investment Management Inc. | 5,995,183 3.300% | -3,241,772![]() (-35.10%) | Filing History |
| 2026-02-17 10:28 am Purchase | 2025-12-31 | 13G | ONESTREAM, INC. CLASS A OS | T. Rowe Price Investment Management Inc. | 7,779,413 8.600% | 3,994,450![]() (+105.53%) | Filing History |

